Moser Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Moser Wealth Advisors's BMY Position: Q1 2025 in Review
Moser Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 135 shares — an estimated $7.64K sold.
Moser Wealth Advisors first reported a position in BMY in Q4 2019 and held it in 10 quarters. The position peaked at $13K in Q1 2021. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Moser Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Moser Wealth Advisors sold 135 Bristol-Myers Squibb shares in Q1 2025, an estimated $7.64K.
- Moser Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 10 quarters.
- Moser Wealth Advisors's Bristol-Myers Squibb position peaked at $13K in Q1 2021.
- 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Moser Wealth Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.